text: San Antonio, TX - SABCS 2012 San Antonio Breast Cancer Symposium: C Denkert discusses S4-5. Ki67 levels in pretherapeutic core biopsies as predictive and prognostic parameters in the neoadjuvant GeparTrio trial during the General Session 4 at the 2012 San Antonio Breast Cancer Symposium here today, Thursday December 6, 2012. Over 9,000 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Date: Thursday December 6, 2012 Photo by © SABCS/Todd Buchanan 2012 Technical Questions: todd@medmeetingimages.com; Phone: 612-226-5154.